Cargando…
Rodent animal models: from mild to advanced stages of diabetic nephropathy
Diabetic nephropathy (DN) is a secondary complication of both type 1 and type 2 diabetes, resulting from uncontrolled high blood sugar. 30–40 % of diabetic patients develop DN associated with a poor life expectancy and end-stage renal disease, causing serious socioeconomic problems. Although an exac...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Basel
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101706/ https://www.ncbi.nlm.nih.gov/pubmed/25149089 http://dx.doi.org/10.1007/s10787-014-0215-y |
_version_ | 1783511678905745408 |
---|---|
author | Kaur, Manpreet Bedi, Onkar Sachdeva, Shilpi Reddy, B. V. K. Krishna Kumar, Puneet |
author_facet | Kaur, Manpreet Bedi, Onkar Sachdeva, Shilpi Reddy, B. V. K. Krishna Kumar, Puneet |
author_sort | Kaur, Manpreet |
collection | PubMed |
description | Diabetic nephropathy (DN) is a secondary complication of both type 1 and type 2 diabetes, resulting from uncontrolled high blood sugar. 30–40 % of diabetic patients develop DN associated with a poor life expectancy and end-stage renal disease, causing serious socioeconomic problems. Although an exact pathogenesis of DN is still unknown, several factors such as hyperglycemia, hyperlipidemia, hypertension and proteinuria may contribute to the progression of renal damage in diabetic nephropathy. DN is confirmed by measuring blood urea nitrogen, serum creatinine, creatinine clearance and proteinuria. Clinical studies show that intensive control of hyperglycemia and blood pressure could successfully reduce proteinuria, which is the main sign of glomerular lesions in DN, and improve the renal prognosis in patients with DN. Diabetic rodent models have traditionally been used for doing research on pathogenesis and developing novel therapeutic strategies, but have limitations for translational research. Diabetes in animal models such as rodents are induced either spontaneously or by using chemical, surgical, genetic, or other techniques and depicts many clinical features or related phenotypes of the disease. This review discusses the merits and demerits of the models, which are used for many reasons in the research of diabetes and diabetic complications. |
format | Online Article Text |
id | pubmed-7101706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Basel |
record_format | MEDLINE/PubMed |
spelling | pubmed-71017062020-03-31 Rodent animal models: from mild to advanced stages of diabetic nephropathy Kaur, Manpreet Bedi, Onkar Sachdeva, Shilpi Reddy, B. V. K. Krishna Kumar, Puneet Inflammopharmacology Review Diabetic nephropathy (DN) is a secondary complication of both type 1 and type 2 diabetes, resulting from uncontrolled high blood sugar. 30–40 % of diabetic patients develop DN associated with a poor life expectancy and end-stage renal disease, causing serious socioeconomic problems. Although an exact pathogenesis of DN is still unknown, several factors such as hyperglycemia, hyperlipidemia, hypertension and proteinuria may contribute to the progression of renal damage in diabetic nephropathy. DN is confirmed by measuring blood urea nitrogen, serum creatinine, creatinine clearance and proteinuria. Clinical studies show that intensive control of hyperglycemia and blood pressure could successfully reduce proteinuria, which is the main sign of glomerular lesions in DN, and improve the renal prognosis in patients with DN. Diabetic rodent models have traditionally been used for doing research on pathogenesis and developing novel therapeutic strategies, but have limitations for translational research. Diabetes in animal models such as rodents are induced either spontaneously or by using chemical, surgical, genetic, or other techniques and depicts many clinical features or related phenotypes of the disease. This review discusses the merits and demerits of the models, which are used for many reasons in the research of diabetes and diabetic complications. Springer Basel 2014-08-23 2014 /pmc/articles/PMC7101706/ /pubmed/25149089 http://dx.doi.org/10.1007/s10787-014-0215-y Text en © Springer Basel 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Kaur, Manpreet Bedi, Onkar Sachdeva, Shilpi Reddy, B. V. K. Krishna Kumar, Puneet Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title | Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title_full | Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title_fullStr | Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title_full_unstemmed | Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title_short | Rodent animal models: from mild to advanced stages of diabetic nephropathy |
title_sort | rodent animal models: from mild to advanced stages of diabetic nephropathy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101706/ https://www.ncbi.nlm.nih.gov/pubmed/25149089 http://dx.doi.org/10.1007/s10787-014-0215-y |
work_keys_str_mv | AT kaurmanpreet rodentanimalmodelsfrommildtoadvancedstagesofdiabeticnephropathy AT bedionkar rodentanimalmodelsfrommildtoadvancedstagesofdiabeticnephropathy AT sachdevashilpi rodentanimalmodelsfrommildtoadvancedstagesofdiabeticnephropathy AT reddybvkkrishna rodentanimalmodelsfrommildtoadvancedstagesofdiabeticnephropathy AT kumarpuneet rodentanimalmodelsfrommildtoadvancedstagesofdiabeticnephropathy |